Katherine J. Holzer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Katherine J. Holzer has a total of 155 co-authors. Here are the top co-authors by number of shared publications:
Michael G. Vaughn
School of Social Work, College for Public Health and Social Justice, Saint Louis University, St. Louis, Missouri, 63103, United States; Graduate School of Social Welfare, Yonsei University, Seoul, Republic of Korea
14 shared publicationsChristopher P. Salas-Wright
School of Social Work, Boston University , Boston, MA, USA
7 shared publicationsSimon Haroutounian
Department of Anesthesiology, St. Louis, MO, USA; AI for Health Institute, Washington University in St. Louis, St. Louis, MO, USA
7 shared publications- Jason T. Carbone
School of Social Work, Wayne State University, Detroit, Michigan, USA
4 shared publications Matt DeLisi
Department of Sociology, Iowa State University, Ames, IA, 50011, United States
4 shared publicationsSehun Oh
College of Social Work, Ohio State University , Columbus, OH, USA
4 shared publications
Latest Publications
- 28 September 2026
- Published by Wolters Kluwer Health in Pain
- Vol. 167  (11) , 2489-2492
Voices in pain: coproduction, creative methods, and communicating chemotherapy-induced painful neuropathy
Was not provided for this article.
- 28 September 2026
- Published by Wolters Kluwer Health in Pain
- Vol. 167  (11) , 2489-2492
Voices in pain: coproduction, creative methods, and communicating chemotherapy-induced painful neuropathy
Was not provided for this article.
- 8 May 2026
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 137  (1) , 371-374
Remote perioperative symptom monitoring through a smartphone is feasible: evidence from the Personalised Prediction of Persistent Postsurgical Pain (P5) study
- 8 May 2026
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 137  (1) , 371-374
Remote perioperative symptom monitoring through a smartphone is feasible: evidence from the Personalised Prediction of Persistent Postsurgical Pain (P5) study
- Open Access
Protocol for Personalised Prediction of Persistent Postsurgical Pain
Introduction: Persistent postsurgical pain (PPSP) affects up to 15% of patients after major surgery, impairing physical function, quality of life and increasing risk for long-term opioid use. Current PPSP prediction models rely on static or retrospective data and fail to incorporate dynamic perioperative factors. The Personalised Prediction of Persistent Postsurgical Pain (P5) study aims to develop individualised, multimodal prediction models by integrating preoperative behavioural, psychophysical and neurocognitive assessments and high-frequency symptom monitoring. Methods and analysis: P5 is a prospective, single-centre cohort study enrolling 2500 adults aged 18–75 undergoing major surgery at a tertiary academic hospital. Participants complete baseline surveys, cognitive testing and quantitative sensory testing preoperatively. Ecological momentary assessments (EMAs) are collected via smartphone three times per day through 30 days postoperatively, capturing pain, mood, catastrophising and medication use. Participants are assessed on postoperative day 1 and complete online surveys at 3 and 6 months, evaluating pain persistence, interference, neuropathic symptoms and related outcomes. Clinical and perioperative data are extracted from the electronic health record. The primary outcome is PPSP at 3 months. Predictive models will be developed using supervised machine learning and dynamic structural equation modelling to extract latent features from EMA data. Model performance will be assessed using area under the receiver operating characteristic curve, area under the precision-recall curve and SHapley Additive exPlanations for interpretability. Ethics and dissemination: This study has received ethics approval from the Washington University School of Medicine Institutional Review Board #202101123. Informed consent is required. Results will be submitted for publication in peer-reviewed journals and presented at research conferences. Trial registration number: NCT04864275 .
Open AccessProtocol for Personalised Prediction of Persistent Postsurgical Pain
Introduction: Persistent postsurgical pain (PPSP) affects up to 15% of patients after major surgery, impairing physical function, quality of life and increasing risk for long-term opioid use. Current PPSP prediction models rely on static or retrospective data and fail to incorporate dynamic perioperative factors. The Personalised Prediction of Persistent Postsurgical Pain (P5) study aims to develop individualised, multimodal prediction models by integrating preoperative behavioural, psychophysical and neurocognitive assessments and high-frequency symptom monitoring. Methods and analysis: P5 is a prospective, single-centre cohort study enrolling 2500 adults aged 18–75 undergoing major surgery at a tertiary academic hospital. Participants complete baseline surveys, cognitive testing and quantitative sensory testing preoperatively. Ecological momentary assessments (EMAs) are collected via smartphone three times per day through 30 days postoperatively, capturing pain, mood, catastrophising and medication use. Participants are assessed on postoperative day 1 and complete online surveys at 3 and 6 months, evaluating pain persistence, interference, neuropathic symptoms and related outcomes. Clinical and perioperative data are extracted from the electronic health record. The primary outcome is PPSP at 3 months. Predictive models will be developed using supervised machine learning and dynamic structural equation modelling to extract latent features from EMA data. Model performance will be assessed using area under the receiver operating characteristic curve, area under the precision-recall curve and SHapley Additive exPlanations for interpretability. Ethics and dissemination: This study has received ethics approval from the Washington University School of Medicine Institutional Review Board #202101123. Informed consent is required. Results will be submitted for publication in peer-reviewed journals and presented at research conferences. Trial registration number: NCT04864275 .
- 17 October 2025
- Published by Taylor & Francis in Journal of Pain & Palliative Care Pharmacotherapy
- Vol. 40  (1) , 1-12
Patient and Clinician Views on Risk Prediction for Chemotherapy-Induced Peripheral Neuropathy
Chemotherapy-induced peripheral neuropathy (CIPN) is a common, often debilitating side effect of oxaliplatin, a standard treatment for colorectal cancer. CIPN can cause pain, functional impairment, and cold hypersensitivity, frequently leading to treatment modifications that impact both quality of life and clinical outcomes. Although risk factors are known, no validated tools exist to predict an individual's CIPN risk, limiting opportunities for proactive management. This study explored patient and clinician perspectives on CIPN risk, its effects on treatment and daily life, and the potential value of risk prediction. Semi-structured interviews were conducted with six patients with colorectal cancer treated with oxaliplatin and six clinicians (four oncologists, two nurse practitioners) from an academic hospital. Thematic analysis identified shared concerns and needs related to CIPN. Clinicians consistently described neuropathy as oxaliplatin's most concerning side effect and reported that it often necessitated dose modifications. Patients reported sensory disturbances, functional limitations, and significant lifestyle disruption. Both groups expressed strong interest in tools to predict CIPN risk, with clinicians emphasizing the importance of clinically actionable, accurate, and workflow-integrated approaches. Findings highlight the potential of CIPN risk prediction to improve care and support treatment decisions, while demonstrating the need for strategies that balance efficacy with quality-of-life considerations.
- 17 October 2025
- Published by Taylor & Francis in Journal of Pain & Palliative Care Pharmacotherapy
- Vol. 40  (1) , 1-12
Patient and Clinician Views on Risk Prediction for Chemotherapy-Induced Peripheral Neuropathy
Chemotherapy-induced peripheral neuropathy (CIPN) is a common, often debilitating side effect of oxaliplatin, a standard treatment for colorectal cancer. CIPN can cause pain, functional impairment, and cold hypersensitivity, frequently leading to treatment modifications that impact both quality of life and clinical outcomes. Although risk factors are known, no validated tools exist to predict an individual's CIPN risk, limiting opportunities for proactive management. This study explored patient and clinician perspectives on CIPN risk, its effects on treatment and daily life, and the potential value of risk prediction. Semi-structured interviews were conducted with six patients with colorectal cancer treated with oxaliplatin and six clinicians (four oncologists, two nurse practitioners) from an academic hospital. Thematic analysis identified shared concerns and needs related to CIPN. Clinicians consistently described neuropathy as oxaliplatin's most concerning side effect and reported that it often necessitated dose modifications. Patients reported sensory disturbances, functional limitations, and significant lifestyle disruption. Both groups expressed strong interest in tools to predict CIPN risk, with clinicians emphasizing the importance of clinically actionable, accurate, and workflow-integrated approaches. Findings highlight the potential of CIPN risk prediction to improve care and support treatment decisions, while demonstrating the need for strategies that balance efficacy with quality-of-life considerations.
- 7 March 2025
- Published by Elsevier in The Journal of Pain
- Vol. 32, 105358
Attitudes toward patient engagement in clinical pain research: Insights from individuals with chronic pain in the United States
- 7 March 2025
- Published by Elsevier in The Journal of Pain
- Vol. 32, 105358
Attitudes toward patient engagement in clinical pain research: Insights from individuals with chronic pain in the United States
- 24 October 2024
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 134  (1) , 102-110
Preoperative predictors of acute postoperative anxiety and depression using ecological momentary assessments: a secondary analysis of a single-centre prospective observational study
- 24 October 2024
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 134  (1) , 102-110
Preoperative predictors of acute postoperative anxiety and depression using ecological momentary assessments: a secondary analysis of a single-centre prospective observational study
- 23 August 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 365, 476-491
The impact of compassion-based interventions on perioperative anxiety and depression: A systematic review and meta-analysis
- 23 August 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 365, 476-491
The impact of compassion-based interventions on perioperative anxiety and depression: A systematic review and meta-analysis
- Open Access
Perioperative mental health intervention for depression and anxiety symptoms in older adults study protocol: design and methods for three linked randomised controlled trials
Introduction Preoperative anxiety and depression symptoms among older surgical patients are associated with poor postoperative outcomes, yet evidence-based interventions for anxiety and depression have not been applied within this setting. We present a protocol for randomised controlled trials (RCTs) in three surgical cohorts: cardiac, oncological and orthopaedic, investigating whether a perioperative mental health intervention, with psychological and pharmacological components, reduces perioperative symptoms of depression and anxiety in older surgical patients. Methods and analysis Adults ≥60 years undergoing cardiac, orthopaedic or oncological surgery will be enrolled in one of three-linked type 1 hybrid effectiveness/implementation RCTs that will be conducted in tandem with similar methods. In each trial, 100 participants will be randomised to a remotely delivered perioperative behavioural treatment incorporating principles of behavioural activation, compassion and care coordination, and medication optimisation, or enhanced usual care with mental health-related resources for this population. The primary outcome is change in depression and anxiety symptoms assessed with the Patient Health Questionnaire-Anxiety Depression Scale from baseline to 3 months post surgery. Other outcomes include quality of life, delirium, length of stay, falls, rehospitalisation, pain and implementation outcomes, including study and intervention reach, acceptability, feasibility and appropriateness, and patient experience with the intervention. Ethics and dissemination The trials have received ethics approval from the Washington University School of Medicine Institutional Review Board. Informed consent is required for participation in the trials. The results will be submitted for publication in peer-reviewed journals, presented at clinical research conferences and disseminated via the Center for Perioperative Mental Health website. Trial registration numbers NCT05575128, NCT05685511, NCT05697835, pre-results.
Open AccessPerioperative mental health intervention for depression and anxiety symptoms in older adults study protocol: design and methods for three linked randomised controlled trials
Introduction Preoperative anxiety and depression symptoms among older surgical patients are associated with poor postoperative outcomes, yet evidence-based interventions for anxiety and depression have not been applied within this setting. We present a protocol for randomised controlled trials (RCTs) in three surgical cohorts: cardiac, oncological and orthopaedic, investigating whether a perioperative mental health intervention, with psychological and pharmacological components, reduces perioperative symptoms of depression and anxiety in older surgical patients. Methods and analysis Adults ≥60 years undergoing cardiac, orthopaedic or oncological surgery will be enrolled in one of three-linked type 1 hybrid effectiveness/implementation RCTs that will be conducted in tandem with similar methods. In each trial, 100 participants will be randomised to a remotely delivered perioperative behavioural treatment incorporating principles of behavioural activation, compassion and care coordination, and medication optimisation, or enhanced usual care with mental health-related resources for this population. The primary outcome is change in depression and anxiety symptoms assessed with the Patient Health Questionnaire-Anxiety Depression Scale from baseline to 3 months post surgery. Other outcomes include quality of life, delirium, length of stay, falls, rehospitalisation, pain and implementation outcomes, including study and intervention reach, acceptability, feasibility and appropriateness, and patient experience with the intervention. Ethics and dissemination The trials have received ethics approval from the Washington University School of Medicine Institutional Review Board. Informed consent is required for participation in the trials. The results will be submitted for publication in peer-reviewed journals, presented at clinical research conferences and disseminated via the Center for Perioperative Mental Health website. Trial registration numbers NCT05575128, NCT05685511, NCT05697835, pre-results.
- Open Access
- 12 February 2024
- Published by Wolters Kluwer Health in Pain Reports
- Vol. 9  (2) , e1120
Cognitive flexibility training for chronic pain: a randomized clinical study
Introduction: Previous studies suggest an association between cognitive flexibility and development of chronic pain after surgery. It is not known whether cognitive flexibility can be improved in patients with chronic pain. Objectives: This study tested whether a neurocognitive training program results in improved cognitive flexibility and pain in patients with chronic pain. Methods: We conducted a single-center, prospective, randomized study investigating 5-week daily neurocognitive training in patients with chronic pain. Participants (n = 145) were randomized into neurocognitive training or care as usual, and they completed assessments at baseline, posttreatment, and 3 months. The treatment group was asked to spend 35 minutes daily completing a program with tasks on cognitive flexibility, memory, attention, and speed. The primary outcome was performance on the neurocognitive performance test (NCPT). Secondary outcomes included levels of pain interference and severity. Results: At 5 weeks, the treatment group showed greater improvements on NCPT compared with the control group (d = 0.37); effect size was smaller at 3 months (d = 0.18). The treatment group reported lower pain severity at 5 weeks (d = 0.16) and 3 months (d = 0.39) than the control group, but pain interference was only lower at 3 months (d = 0.20). Conclusions: Outcomes suggest that using neurocognitive training to modify cognitive flexibility in patients with chronic pain may improve pain severity. This study provided effect size estimates to inform sample size calculations for randomized controlled trials to test the effectiveness of neurocognitive interventions for the prevention and treatment of chronic pain.
- 12 February 2024
- Published by Wolters Kluwer Health in Pain Reports
- Vol. 9  (2) , e1120
Open AccessCognitive flexibility training for chronic pain: a randomized clinical study
Introduction: Previous studies suggest an association between cognitive flexibility and development of chronic pain after surgery. It is not known whether cognitive flexibility can be improved in patients with chronic pain. Objectives: This study tested whether a neurocognitive training program results in improved cognitive flexibility and pain in patients with chronic pain. Methods: We conducted a single-center, prospective, randomized study investigating 5-week daily neurocognitive training in patients with chronic pain. Participants (n = 145) were randomized into neurocognitive training or care as usual, and they completed assessments at baseline, posttreatment, and 3 months. The treatment group was asked to spend 35 minutes daily completing a program with tasks on cognitive flexibility, memory, attention, and speed. The primary outcome was performance on the neurocognitive performance test (NCPT). Secondary outcomes included levels of pain interference and severity. Results: At 5 weeks, the treatment group showed greater improvements on NCPT compared with the control group (d = 0.37); effect size was smaller at 3 months (d = 0.18). The treatment group reported lower pain severity at 5 weeks (d = 0.16) and 3 months (d = 0.39) than the control group, but pain interference was only lower at 3 months (d = 0.20). Conclusions: Outcomes suggest that using neurocognitive training to modify cognitive flexibility in patients with chronic pain may improve pain severity. This study provided effect size estimates to inform sample size calculations for randomized controlled trials to test the effectiveness of neurocognitive interventions for the prevention and treatment of chronic pain.